Medicare Enrolled

Dr. Jennifer Stalkup, M.D.

Pediatric Dermatology Physician · Plano, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
6100 WINDHAVEN PKWY, Plano, TX 75093
2146151900
Registered in NPPES since 2006
NPI: 1548297278 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Stalkup from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stalkup? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Stalkup

Dr. Jennifer Stalkup is a pediatric dermatology physician in Plano, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Stalkup performed 6,283 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Stalkup received a total of $5,503 from 35 pharmaceutical and/or device companies across 319 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Stalkup is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 27% volume in TX $5,503 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
6,283
Medicare services
Top 27% in TX for pediatric dermatology physician
Not available
Unique patients (not deduplicated)
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
2,643 $4 $25
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,459 $60 $85
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
857 $31 $100
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
526 $73 $150
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
407 $58 $150
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
100 $35 $75
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
56 $107 $350
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
53 $39 $60
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
51 $85 $130
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
36 $76 $150
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
33 $124 $240
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
22 $1 $8
Punch biopsy of first skin growth
A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination.
14 $91 $150
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
14 $28 $75
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
12 $44 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,503
Total received (2018-2024)
Avg $786/year across 7 years
Top 41% in TX for pediatric dermatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
319
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,256
2023
$869
2022
$834
2021
$777
2020
$522
2019
$398
2018
$849

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$382
Regeneron Healthcare Solutions, Inc.
$220
Lilly USA, LLC
$200
ABBVIE INC.
$133
Janssen Biotech, Inc.
$120
Amgen Inc.
$49
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
PFIZER INC.
$30
Dermavant Sciences, Inc.
$22
Incyte Corporation
$21
Ortho Dermatologics, a division of Bausch Health US, LLC
$16
E.R. Squibb & Sons, L.L.C.
$16
UCB, Inc.
$16
Top 3 companies account for 63.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,029
Lilly USA, LLC
$429
Misonix Inc
$395
Ortho Dermatologics, a division of Bausch Health US, LLC
$390
Regeneron Healthcare Solutions, Inc.
$378
ABBVIE INC.
$352
Janssen Biotech, Inc.
$245
AbbVie Inc.
$213
Galderma Laboratories, L.P.
$211
LEO Pharma Inc.
$189
Amgen Inc.
$146
PFIZER INC.
$141
Dermavant Sciences, Inc.
$131
Incyte Corporation
$108
Encore Dermatology Inc.
$96
AbbVie, Inc.
$94
Sun Pharmaceutical Industries Inc.
$93
Celgene Corporation
$86
Mayne Pharma Inc.
$80
Taro Pharmaceuticals USA, Inc.
$73
Nabriva Therapeutics, plc
$72
VYNE Pharmaceuticals Inc.
$71
SUN PHARMACEUTICAL INDUSTRIES INC.
$71
Almirall LLC
$56
GENZYME CORPORATION
$48
E.R. Squibb & Sons, L.L.C.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
EPI Health, LLC
$43
Aclaris Therapeutics, Inc.
$41
UCB, Inc.
$35
Allergan Inc.
$24
Octapharma USA, Inc.
$23
TARO PHARMACEUTICALS USA, INC.
$19
Paratek Pharmaceuticals, Inc.
$15
MAYNE PHARMA INC.
$12
Top 3 companies account for 33.7% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ADBRY · AKLIEF · AMZEEQ · ARAZLO · BOTOX COSMETIC · BRYHALI · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · DORYX · DUOBRII · DUPIXENT · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · ESKATA · EUCRISA · HALOG (Halcinonide Cream · HUMIRA · Halog · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · Klisyri · LIBTAYO · LUZU LULICONAZOLE · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORACEA · Otezla · PICATO · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Seysara · Sivextro · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TWYNEO · Tremfya · USP) 0.1% · VTAMA · Winlevi
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pediatric dermatology physician in Plano?
Compare pediatric dermatology physicians in the Plano area by procedure volume, costs, and industry payment transparency.
Browse pediatric dermatology physicians nearby

Geographic Context

Pediatric dermatology physicians in nearby ZIP areas
5
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Stalkup is a clinical cardiology specialist, with above-average Medicare volume (top 27% in TX), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Stalkup experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Stalkup performed 2,643 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Stalkup receive payments from pharmaceutical companies?
Yes. Dr. Stalkup received a total of $5,503 from 35 companies across 319 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stalkup's costs compare to other pediatric dermatology physicians in Plano?
Dr. Stalkup's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stalkup) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →